WASHINGTON, D.C. - A subsidiary of Pfizer Inc. will pay $60.1 million in a fine, disgorgement and interest to settle federal criminal and civil allegations that Pfizer and Wyeth paid bribes to officials and doctors in several foreign countries to induce them to buy the companies' drugs, according to settlements announced Aug. 7 by the U.S. Department of Justice (DOJ), the U.S. Securities and Exchange Commission and Pfizer (United States of America v. Pfizer H.C.P. Corporation, No. 1:12-cr-169, U.S. Securities and Exchange Commission v. Pfizer, Inc., No 12-1303, and U.S. Securities and Exchange Commission v. Wyeth LLC, No. 12-1304, D. D.C.). Subscribers may view the agreement documents, consent and proposed judgment available within the full Mealey's article.